Screen strategies for off-target liability prediction and identifying small-molecule pharmaceuticals

September 11, 2018, SLAS (Society for Laboratory Automation and Screening)
Example of a drug development paradigm incorporating multi-step screening and showing relationships between data that can be integrated to combine complimentary data sets that provide a more complete picture of drug-related effects. Credit: Van Vleet et al. (AbbVie, Chicago, IL USA)

A new review in SLAS Discovery explores how improved safety screening strategies and methods are improving the pharmaceutical discovery and development process. Terry R. Van Vleet et al. of AbbVie (Chicago, IL USA) outline several fundamental methods of the current drug screening processes and emerging techniques and technologies that promise to improve molecule selection. In addition, the authors discuss integrated screening strategies and provide examples of advanced screening paradigms.

Pharmaceutical and development is a long and expensive process that, unfortunately, still results in a low success rate, with drug safety continuing to be a major impedance. Improved safety screening strategies and methods are needed to more effectively fill this critical gap.

Recent advances in informatics are now making it possible to manage bigger data sets and integrate multiple sources of screening data in a manner that can potentially improve the selection of higher-quality drug candidates. Integrated screening paradigms have become the norm in pharma, both in discovery screening and in the identification of off-target toxicity mechanisms during later-stage .

Furthermore, advances in computational methods are making in silico screens more relevant and suggest that they may represent a feasible option for augmenting the current paradigm.

Explore further: Integrated lead discovery: An evolving toolbox

More information: Terry R. Van Vleet et al, Screening Strategies and Methods for Better Off-Target Liability Prediction and Identification of Small-Molecule Pharmaceuticals, SLAS DISCOVERY: Advancing Life Sciences R&D (2018). DOI: 10.1177/2472555218799713

Related Stories

Integrated lead discovery: An evolving toolbox

June 15, 2018
A new SLAS Discovery review article by GlaxoSmithKline researchers in the U.S. and U.K. offers an informative guide to the established and emerging tools available for early drug discovery and screening, and provides illustrative ...

Women's Preventive Services Initiative says screen all women annually for urinary incontinence

August 13, 2018
All women should be screened annually for urinary incontinence, according to new guidelines from the Women's Preventive Services Initiative (WPSI). Screening should assess whether women experience urinary incontinence and ...

CCHD newborn screening may detect other diseases

April 30, 2018
(HealthDay)—Critical congenital heart disease (CCHD) newborn screening detects a low percentage of new cases of CCHD, but it can detect other important diseases, according to a study published online April 24 in Pediatrics.

Prediction tool helps tailor lung cancer screening to patients

May 30, 2018
(HealthDay)—Personalizing the harm-benefit assessment of low-dose computed tomography (LDCT) screening for lung cancer can inform patient-centered screening decisions, according to a study published online May 29 in the ...

Stem cell-based screening methods may predict heart-related side effects of drugs

September 19, 2016
Coaxing stem cells from patients to become heart cells may help clinicians personalize drug treatments and prevent heart-related toxicity.

Recommended for you

Probiotic use may reduce antibiotic prescriptions, researchers say

September 14, 2018
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Recalled blood pressure drugs not linked to increased short term cancer risk

September 12, 2018
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased short term risk of cancer, finds an expedited analysis published by The BMJ today.

Sugar pills relieve pain for chronic pain patients

September 12, 2018
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

One in four older adults prescribed a benzodiazepine goes on to risky long-term use

September 10, 2018
They may start as well-intentioned efforts to calm anxiety, improve sleep or ease depression. But prescriptions for sedatives known as benzodiazepines may lead to long-term use among one in four older adults who receive them, ...

Clinical need absent, unclear in nearly 30 percent of outpatient opioid prescriptions

September 10, 2018
Nearly 30 percent of outpatient opioid prescriptions in the United States lack documented clinical reasons that justify the use of these potent drugs, according to a national analysis of physician visit records conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.